Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

8.300 +1.470 (+21.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
Via Chartmill
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
Earnings Scheduled For September 15, 2025
 
Via Benzinga
Insights Ahead: Champions Oncology's Quarterly Earnings
 
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Via ACCESS Newswire
Champions Oncology Reports Record Annual Revenue of $57 Million
Via ACCESS Newswire
Earnings Scheduled For July 23, 2025
 
Via Benzinga
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline. 
Via Benzinga
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
Via ACCESS Newswire
Champions Oncology Announces Appointment of New CEO
Via ACCESS Newswire
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Via ACCESS Newswire
Recap: Champions Oncology Q2 Earnings
 
Via Benzinga
A Peek at Champions Oncology's Future Earnings
 
Via Benzinga
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Via ACCESS Newswire
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
Via ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
Via ACCESS Newswire
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Via ACCESS Newswire
Earnings Scheduled For March 11, 2025
 
Via Benzinga
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
Via ACCESS Newswire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Via ACCESSWIRE
Earnings Scheduled For December 11, 2024
 
Via Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
Via ACCESSWIRE
Champions Oncology Announces Agreement with Weill Cornell Medicine
Via ACCESSWIRE
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
 
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.